Latest Breaking News On - Global vitiligo foundation - Page 1 : comparemela.com

Iltefat Hamzavi, MD: Long-Term Implications of New Data on Upadacitinib for Nonsegmental Vitiligo

In this segment of his AAD interview, Hamzavi discussed more about his team’s findings on upadacitinib as well as their implications and future in terms of research.

Iltefat Hamzavi, MD: New Phase 2b Findings on Upadacitinib for Non-Segmental Vitiligo

Hamzavi discusses new late-breaking data from AAD 2024, including major takeaways and safety profile after 52 weeks.

Dr. Pearl Grimes, Dermatologist: Interview

Dr. Pearl Grimes is a dermatologist known as an expert in the field of vitiligo and pigmentation disorders. Read about why she's a PS Black Health Hero.

VYNE Therapeutics (VYNE) Reports Positive Biomarker Data from Successful Phase 1b Trial of VYN201

VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo